- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05337644
Indocyanine Green Test for Evaluation of Perfusion of Staple Line of the Stomach During Laparoscopic Sleeve Gastrectomy
April 14, 2022 updated by: Giovanna Pavone, University of Foggia
Leak After Sleeve Gastrectomy With Positive Intraoperative Indocyanine Green Test: Avoidable Scenario?
The investigators present the case of a 40-year-old female underwent laparoscopic sleeve gastrectomy.
Intraoperative indocyanine green test was performed
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Foggia, Italy, 71122
- University of Foggia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Obese patients with BMI >40 kg/m2 underwent laparoscopic Sleeve gastrectomy
Description
Inclusion Criteria:
- BMI >40 kg/m2
Exclusion Criteria:
- Non-obese patients
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive Intraoperative Indocyanine green test
Time Frame: from 20 January 2022 to 20 January 2022
|
Intraoperative indocyanine green test was performed
|
from 20 January 2022 to 20 January 2022
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Antonio Ambrosi, University of Foggia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 21, 2022
Primary Completion (Actual)
February 6, 2022
Study Completion (Actual)
March 25, 2022
Study Registration Dates
First Submitted
March 30, 2022
First Submitted That Met QC Criteria
April 14, 2022
First Posted (Actual)
April 20, 2022
Study Record Updates
Last Update Posted (Actual)
April 20, 2022
Last Update Submitted That Met QC Criteria
April 14, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Diseases
-
Leiden University Medical CenterRecruitingVascular Disease,PeripheralNetherlands
-
W.L.Gore & AssociatesActive, not recruitingPeripheral Vascular DiseasesGermany, Netherlands, France, Italy, Spain
-
Boston Scientific CorporationRecruitingPeripheral Vascular DiseasesUnited States, Australia, Taiwan, Thailand, Austria, Germany, Canada, France, China, Spain, Poland
-
Midwest Cardiovascular Research FoundationCompletedPeripheral Vascular DiseaseUnited States
-
SensomeCompletedPeripheral Vascular DiseaseBelgium
-
The Methodist Hospital Research InstituteNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPeripheral Vascular DiseasesUnited States
-
Rijnstate HospitalCompletedPeripheral Vascular DiseasesNetherlands
-
Terumo Europe N.V.CompletedPeripheral Vascular Disease | Hemostasis | Vascular Closure | Endovascular ProcedureBelgium, France, Germany
-
Alvotech Swiss AGCompletedChorioretinal Vascular DiseaseGeorgia
-
AmgenCompletedChorioretinal Vascular DiseaseUnited States
Clinical Trials on Indocyanine green solution
-
Haseki Training and Research HospitalUnknownEndometrial Cancer | Sentinel Lymph Node | Indocyanine GreenTurkey
-
Aristotle University Of ThessalonikiCompletedThyroid | Parathyroid; DeficiencyGreece
-
Fujian Medical University Union HospitalRecruitingEsophageal Cancer | Indocyanine GreenChina
-
Ohio State University Comprehensive Cancer CenterCompletedNeck Dissection | Radical Lymph Node DissectionUnited States
-
University of PennsylvaniaCompletedIschemic Stroke | Traumatic Brain Injury | Subarachnoid Hemorrhage | Intracerebral Hemorrhage | Acute Anoxic EncephalopathyUnited States
-
Corporacion Parc TauliRecruitingAcute Cholecystitis | Bile Duct InjurySpain
-
Oxford University Hospitals NHS TrustUniversity of OxfordTerminatedRectal Cancer | Surgery | Urethra InjuryUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCompletedNecrotising FasciitisUnited States
-
University Medical Center GroningenRecruitingGastric Carcinoma | Esophageal CarcinomaNetherlands
-
University of FoggiaCompleted